DonaldWashington

That makes sense. I will try and do that. Thanks for the quick clarification

Sorry - kind of new to posting here

DonaldWashington

What do you mean more accessible? T

flyingcuttlefish

This belongs in the news section. Wrong subverse.

DonaldWashington

This has pizzagate written all over it. The Clintons intentionally disrupted the medicine supply in Africa causing a huge surge in disease. This allowed their friends to profit from USAID, and it gave them a massive pool of victims for clinical trials. Big Pharma is all over this, and see my other post.

flyingcuttlefish

yes its a big crime ... but there's no pedo crime in there. pizzagate is about pedos and the DC pedo ring. I put stuff semi-related over on v/pizzagate2

DonaldWashington

'Big pharma' and clinical trials’
SCIENCE MUSEUM UK

  • Pharmaceutical companies spend large sums on developing new drugs.
  • Guidelines were introduced to regulate clinical trials on humans. These were the Nuremberg Code, developed after the Second World War; the 1966 Helsinki Declaration; and the 1974 establishment of the US National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research.

Ugly past of U.S. human experiments uncovered
NBC
FEB 2, 2011

  • “Shocking as it may seem, U.S. government doctors once thought it was fine to experiment on disabled people and prison inmates. Such experiments included giving hepatitis to mental patients in Connecticut, squirting a pandemic flu virus up the noses of prisoners in Maryland, and injecting cancer cells into chronically ill people at a New York hospital.”
  • “Much of this horrific history is 40 to 80 years old, but it is the backdrop for a meeting in Washington this week by a presidential bioethics commission. The meeting was triggered by the government's apology last fall for federal doctors infecting prisoners and mental patients in Guatemala with syphilis 65 years ago.”
  • “U.S. officials also acknowledged there had been dozens of similar experiments in the United States — studies that often involved making healthy people sick.”

Testing Drugs on the Developing World
THE ATLANTIC
FEB 27, 2013

  • For people struggling to put food on the table and a roof over their heads, "voluntary" participation in clinical trials is a slippery slope. While disclosure of new data from pharmaceutical companies is a good first step, questions remain.
  • The purpose of clinical trials is to find out if the newest wonder drug is all that wonderful, and what kind of side effects we humans might expect. It worked on animals, but will this drug kill people, and/or turn them green? Every warning you see on a label is there because a test subject -- or 50 of them, or 500 of them -- have suffered that side effect.

’Many drugs for U.S. kids tested in poor countries’ REUTERS
AUG 23, 2010

  • A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available.
  • "The trend that we describe brings up some scientific and ethical problems," said Dr. Sara K. Pasquali, a pediatrician at Duke University Medical Center in Durham, North Carolina, whose findings appear in the journal Pediatrics.
  • According to the Pharmaceutical Research and Manufacturers of America , a trade association, there is no difference in the way trials are conducted in the U.S. and abroad.
  • "Recruiting people is easy, getting informed consent is easy, getting approval is easy, paying the patients and paying the doctors is easy," Ghayur said. "The physicians and investigators have absolutely no idea about the seriousness of the situation."


LOBBYING FEES PAID TO PODESTA GROUP

YEAR CLIENT AMOUNT
1998 Pharmaceutical Research & Manufacturers of America $120,000
1999 Pharmaceutical Research & Manufacturers of America $140,000
2000 Pharmaceutical Research & Manufacturers of America $160,000
2001 Pharmaceutical Research & Manufacturers of America $20,000
2002 Pharmaceutical Research & Manufacturers of America $160,000
2003 Pharmaceutical Research & Manufacturers of America $330,000
2004 Pharmaceutical Research & Manufacturers of America $360,000
2005 Pharmaceutical Research & Manufacturers of America $360,000
2006 Pharmaceutical Research & Manufacturers of America $360,000

“According to the Pharmaceutical Research and Manufacturers of America , a trade association, there is no difference in the way trials are conducted in the U.S. and abroad.”

DonaldWashington

Hansjorg Wyss

Billionaire CEO of Synthes USA In 2009, top executives at Synthes were indicted by U.S. Attorneys for Eastern Pennsylvania for using an untested calcium-phosphate-based bone cement on human patients without the authorization from the Food and Drug Administration, which resulted in the deaths of three people. Wyss was not indicted but four of Synthes' top executives were convicted and sentenced to prison terms.

Liberal groups refuse to talk about links to funder with tainted history of illegal human experiments

WASHINGTON EXAMINER
JUL 29, 2014

  • Swiss billionaire Hansjorg Wyss, whose former company conducted illegal human experiments where three elderly patients died.
  • The Examiner reported July 23 that John Podesta received $87,000 as a paid consultant to a Wyss-controlled foundation before joining President Obama's inner circle of White House advisers.
  • Podesta has also benefited from the more than $4 million Wyss has given to the Center for American Progress since 2008.
  • Podesta was the founding president of CAP and remains as chairman of its board of directors, which also includes Wyss, former Secretary of State Madeline Albright; former Senate Majority Leader Tom Daschle, D-S.D; and former Obama White House energy czar Carol Browner.
  • The loyalty appears to be reciprocated, as liberal groups continue to remain silent about their acceptance of millions of dollars in donations from the reclusive Swiss billionaire even as CEO Wyss conducted abhorrent human experiments.
  • Wyss, who was Synthes CEO and majority stockholder at the time of the indictment, sold Synthes to Johnson & Johnson in 2012 for $21.3 billion.

‘Bad to the bone: A medical horror story’
FORTUNE
SEP 18, 2012

  • When medical device company Synthes decided to illegally test a bone cement on people, the results were disastrous. A disturbing tale of corporate crime and punishment.
  • Synthes not only disregarded multiple warnings that it was flouting the rules, but also brushed off scientists’ cautions that the cement could cause fatal blood clots.

Examples of unethical trials – SOMO

Trials on foster care children in New York (1997-2002)
Location: New York, New York USA
Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID), US National Institute of Child Health and Human Development (NICHD), Genentech, MicroGeneSystems, Lederle-Praxis Biologicals

  • Phase I and II clinical trials were conducted on HIV-infected children and infants in the guardianship of New York City Agency for Children's Services (ACS), living at Incarnation Children’s Center in Harlem, a foster care facility under contract with ACS. The ACS provided consent for their participation. Children were forced to take the experimental medication that made them severely ill and had potentially lethal side effects.

Guinea Pig Kids
BBC
NOV 29, 2004

  • HIV positive children - some only a few months old - are enrolled in toxic experiments without the consent of guardians or relatives.
  • The city's Administration of Children's Services (ACS) does not even require a court order to place HIV kids with foster parents or in children's homes, where they can continue to give them experimental drugs.

’New York's HIV experiment’
BBC
NOV 30, 2004

  • Jacklyn Hoerger's job was to treat children with HIV at a New York children's home.
  • But nobody had told her that the drugs she was administering were experimental and highly toxic.

Abdullahi v. Pfizer, Inc. – Pfizer testing on African Children in 2007 BBC NEWS

  • In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives traveled to Kano, Nigeria to administer an experimental antibiotic, trovafloxacin, to approximately 200 children. Local Kano officials report that more than 50 children died in the experiment, while many others developed mental and physical deformities.

Tenofovir trials on HIV transmission (2004–2005) THE LANCET Location: Cameroon, Thailand, Nigeria Sponsors: Gilead, US CDC, Bill and Melinda Gates Foundation

SFBC Miami Test Center (2000-2005)
FLORIDA TREND *
MAR 1, 2007
Location: Miami, Florida, USA
Sponsors: Pfizer, Merck & Co, Johnson & Johnson, Schering-Plough, Theravance, Purdue Pharma, AstraZeneca, and others

Risperidone trials in India (2003?)
Location: Gujarat, India Sponsors: Johnson & Johnson Drug trials outsourced to India
BBC
APR 22, 2006

  • During a trial for the treatment of acute mania, psychiatric patients were taken off their existing medication and told that it was discontinued and no longer available. They subsequently received risperidone or a placebo. This was controversial because the patients receiving a placebo could suffer unnecessary harm by being taken off their medication. One patient explained that he signed a form because the doctor required it, but had no idea that he was participating in a clinical trial.

Side Effects May Include Lawsuits NEW YORK TIMES
OCT 2, 2010

  • Every major company selling the antipsychotics — Bristol-Myers Squibb, Eli Lilly, Pfizer, AstraZeneca and Johnson & Johnson — has either settled recent government cases, under the False Claims Act, for hundreds of millions of dollars or is currently under investigation for possible health care fraud.

PODESTA GROUP LOBBYING FEES YEAR | CLIENT | AMOUNT :--|:---:|--: 2012 | Bristol-Myers Squibb | $100,000 1999 | Eli Lilly & Co | $80,000 2000 | Eli Lilly & Co | $80,000 2004 | Pfizer Inc | $100,000 2005 | Pfizer Inc | $180,000 2006 | Pfizer Inc | $240,000 2007 | Pfizer Inc | $40,000 2011 | Johnson & Johnson | $100,000 2012 | Johnson & Johnson | $160,000 2013 | Johnson & Johnson | $200,000 2014 | Johnson & Johnson | $50,000

CLINTON FOUNDATION DONATIONS Johnson & Johnson $100,001 - $250,000 AstraZeneca PLC $100,001 - $250,000 AstraZeneca Pharmaceuticals LP $50,001 - $100,000

DonaldWashington

5

Bill Clinton bombed Saddam to distract from the Monica Lewinsky scandal - what Huma Abedin's Muslim journal claimed about her boss's husband - DAILY MAIL
AUG 26, 2016

  • Huma Abedin, Clinton's right-hand woman, was for 12 years the assistant editor of the Journal of Muslim Minority Affairs.
  • In 2002 the supposedly academic journal published claims by a Canadian law student about the 1998 bombing Bill Clinton ordered in Iraq.
  • Sina Ali Musati claimed he did it as a distraction from the Monica Lewinsky scandal - which was then at its height.
  • Clinton campaign claims Abedin was not involved in actually editing the magazine saying she was 'just on the masthead'.
  • But did not explain how that squared with her being on the editorial board.
  • Her mother is editor-in-chief and suggested U.S. was responsible for 9/11 while another article said Jews were 'adept' at influencing politics.
  • The article was written by Sina Ali Muscati who was the time described as a 'second year law student' at the University of Ottawa. His academic credentials were not declared.
    • Muscati wrote about the 1991 conflict and its aftermath, which saw Saddam Hussein remain in power throughout the 1990s, despite being bombed twice - in 1996 and in December 1998.
    • 'The crisis with Iraq has also probably benefited Clinton, serving as a good deterrent of attention from personal crises, such as his campaign funding scandals, legislative failures, or the Monica Lewinsky affair,' he said.
    • 'By occasionally bombing Iraq in the name of humanity, at least, he has been able to look strong and presidential.'
    • Clinton's bombing of Iraq in December 1998 was widely mocked as 'Monica's war'.
    • He ordered four days of strikes by bombers and cruise missiles at the height of his impeachment trial, brought in the wake of his admission that he had had a 'not appropriate' relationship with Monica Lewinsky.

Sound familiar?

DonaldWashington

4

Clinton Foundation AIDS Program Distributed ‘Watered-Down’ Drugs to Third World Countries - DAILY CALLER
SEP 19, 2016

  • Former President Bill Clinton and his Clinton Health Access Initiative (CHAI) distributed “watered-down” HIV/AIDs drugs to patients in sub-Saharan Africa, and “likely increased” the risks of morbidity and mortality.
  • The CHAI program to help AIDS victims is considered one of the Clinton Foundation’s most important contributions and is probably its best known initiative.
  • Ranbaxy ultimately pleaded guilty in 2013 to seven criminal counts with intent to defraud and the introduction of adulterated drugs into interstate commerce.
  • The Department of Justice further levied a $500 million fine and forfeiture on the company.

    Ranbaxy Pharmaceuticals Inc. donated $100,001 - $250,000 to the Clinton Foundation.

Clinton Foundation Advised World Bank on Contracts That Netted Donors Millions - FREE BEACON
AUG 16, 2016

  • Two of every three dollars spent acquiring anti-tuberculosis drugs through the program, which is administered by the World Bank, have gone to two companies—Swiss health care giant Novartis and Indian drug company Lupin Ltd.—that together have donated up to $130,000 to the Clinton Foundation.
  • The project, dubbed the Second National Tuberculosis Control Project (SNTCP), is financed by the World Bank’s International Development Association, which receives the bulk of its funding from the United States, Britain, Japan, and Germany.
  • Clinton has pointed to her foundation’s work in promoting access to pharmaceuticals in the developing world as an example of its laudatory humanitarian mission.
  • However, critics have noted how beneficiaries of other foundation-backed pharmaceutical access programs have made large financial contributions to the group. Companies that received funds from the foundation to provide low-cost HIV drugs, for instance, were donors to the foundation.

BLACKBURN RELEASES CLINTON FOUNDATION REPORT - CONGRESSMAN MARSHA BLACKBURN
SEP 20, 2016

  • The Clinton Foundation Likely Facilitated The Distribution of Watered Down HIV/AIDS Medications In sub-Saharan Africa Through Its Health Access Initiative.
  • The Distribution of Watered Down HIV/AIDS Medications In sub-Saharan Africa May Have Increased Patient Mortality Rates.
  • Watered Down HIV/AIDS ARVs Were Purchased With Taxpayer Money Through PEPFAR As A Result of Price Agreements, Some of Which Were Likely Negotiated By The Clinton Foundation.
  • President Clinton Was Personally Enriched With Million Dollar Consulting Contracts By A Friend of Convicted Felon, and Ranbaxy advocate, Rajat Gupta From 2002-2008.

Lobbyists for Clinton’s ‘Enemies’ Are Bankrolling Her Campaign - FREE BEACON
OCT 14, 2015

  • Asked to name the enemies that she is most proud of during Tuesday’s Democratic presidential debate, Hillary Clinton cited industries represented by lobbyists who are among her top campaign fundraisers.
  • In addition to Iran and the Republican Party, Clinton said she was proud to count “the health insurance companies” and “the drug companies” as her enemies.
  • Those industries’ lobbyists do not appear to share that enmity. By mid-July, seven of them had raised hundreds of thousands of dollars for her presidential campaign, according to campaign finance records.
  • They include Heather and Tony Podesta, the recently divorced Democratic power brokers. Heather Podesta represents health insurer Cigna, while Tony lobbies on behalf of pharmaceutical firms Amgen and EMD Serono, a division of drug giant Merck.
  • The Podestas have also given as much as $150,000 to the Clinton Foundation, according to that group’s list of donors.
  • Insurers Humana and Blue Cross Blue Shield of North Carolina and drug company Pfizer have donated between $1 million and $5 million. Merck has given $250,000 to $500,000; AstraZeneca and Johnson & Johnson have donated $100,000 to $250,000.
  • One of the speakers at this year’s annual Clinton Global Initiative summit was Merck chairman and chief executive Kenneth Frazier, a PhRMA board member. Last year, CGI hosted the president of health care consulting firm Rabin Martin, which represents a number of drug companies. The year before, it announced financial commitments from Pfizer, one of multiple such charitable commitments that drug company has made through the Clinton Foundation.




Bombing of Iraq (1998) - WIKIPEDIA

  • The December 1998 bombing of Iraq (code-named Operation Desert Fox) was a major four-day bombing campaign on Iraqi targets from December 16, 1998, to December 19, 1998, by the United States and United Kingdom.
  • The contemporaneous justification for the strikes was Iraq's failure to comply with United Nations Security Council resolutions and its interference with United Nations Special Commission inspectors.

Facilities not known to be producing WMD - WASHINGTON POST

  • Former U.S. Army intelligence analyst William Arkin contended in his Washington Post column January, 1999 that the operation had less to do with WMD and more to do with destabilizing the Iraqi government.
    • It is clear from the target list, and from extensive communications with almost a dozen officers and analysts knowledgeable about Desert Fox planning, that the U.S.-British bombing campaign was more than a reflexive reaction to Saddam Hussein's refusal to cooperate with UNSCOM's inspectors.
    • The official rationale for Desert Fox may remain the "degrading" of Iraq's ability to produce weapons of mass destruction and the "diminishing" of the Iraqi threat to its neighbours. But careful study of the target list tells another story.
    • Thirty-five of the 100 targets were selected because of their role in Iraq's air defense system, an essential first step in any air war, because damage to those sites paves the way for other forces and minimizes casualties all around. Only 13 targets on the list are facilities associated with chemical and biological weapons or ballistic missiles, and three are southern Republican Guard bases that might be involved in a repeat invasion of Kuwait.

DonaldWashington

3

World Bank head praises DDT use against malaria - SCI DEV NET
MAR 19, 2007
- World Bank president Paul Wolfowitz has praised South Africa's malaria control programme, saying the country's use of indoor residual spraying has reduced malaria episodes.
- Wolfowitz says he will consider taking South Africa's approach to other malaria-affected countries. He committed around US$48 million for malaria control in 14 African countries, which could increase, depending on success.

’The Malaria Vaccine Funders Group’
The Malaria Vaccine Funders Group - having a joint vision for a major contribution to a world free from malaria morbidity and mortality through vaccination - has its origins in discussions among representatives from the World Health Organization (WHO), the United States Agency for International Development (USAID), the European Commission (EC) and the European Vaccine Initiative (EVI)

  • The Bill & Melinda Gates Foundation (BMGF)
  • The European Commission (EC)
  • The European and Developing Countries Clinical Trials Partnership (EDCTP)
  • The European Vaccine Initiative (EVI)
  • The PATH Malaria Vaccine Initiative (MVI)
  • The National Institute of Allergy and Infectious Diseases (NIAID) Extramural Malaria Program
  • The United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP)
  • The Wellcome Trust
  • The World Health Organization (WHO) Initiative for Vaccine Research (IVR)

This is not limited to Malaria or Clinton.


The President's Emergency Plan For AIDS Relief (PEPFAR/Emergency Plan) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease, primarily in Africa.
Implementing Agencies

  • Office of the Global AIDS Coordinator (OGAC)
  • U.S. Agency for International Development (USAID)
  • Department of Health and Human Services (HHS)
  • Centers for Disease Control and Prevention (CDC)
  • Department of Defense (DoD)
  • Department of Commerce (DoC)
  • Department of Labor (DoL)
  • Peace Corps

The program has provided antiretroviral treatment (ART) to over 7.7 million HIV-infected people in resource-limited settings and supported HIV testing and counseling (HTC) for more than 56.7 million people as of 2014.[1] PEPFAR increased the number of Africans receiving ART from 50,000 at the start of the initiative in 2004.[2][3][4] PEPFAR has been called the largest health initiative ever initiated by one country to address a disease. The budget presented for the fiscal year 2016 included a request for $1.11 billion for PEPFAR as well as contributions from global organizations such as UNAIDS and private donors.

Abdullahi v. Pfizer, Inc. – Pfizer testing on African Children in 2007 - BBC NEWS

  • In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives traveled to Kano, Nigeria to administer an experimental antibiotic, trovafloxacin, to approximately 200 children. Local Kano officials report that more than 50 children died in the experiment, while many others developed mental and physical deformities.

Unethical Clinical Trials Still Being Conducted in Developing Countries - HUFFINGTON POST
OCT 3, 2014

  • In 1997, Public Citizen’s Health Research Group brought widespread international attention to unethical clinical trials.
  • The trials were testing new methods for preventing the spread of HIV infection from pregnant women to their babies before or after giving birth in developing countries in Africa, Asia and the Caribbean.
  • In each of these trials, most of which were funded by the U.S. government, some women were randomly assigned to receive placebos or other treatments known to be ineffective, rather than a drug proven effective in preventing the spread of HIV infection from mother to baby.


Malaria drug causes brain damage that mimics PTSD: case study - MILITARY TIMES
AUG 11, 2016

  • The case of a service member diagnosed with post-traumatic stress disorder but found instead to have brain damage caused by a malaria drug raises questions about the origin of similar symptoms in other post-9/11 veterans.
  • According to the case study published online in Drug Safety Case Reports in June, a U.S. military member sought treatment at Walter Reed National Military Medical Center in Bethesda, Maryland, for uncontrolled anger, insomnia, nightmares and memory loss.

The fix is in

Leaked Podesta email discussing price fixing AIDS drugs for their benefit. - WIKILEAKS
RE: Domestic AIDS Memo
DEC 12, 2011

  • “We were taken by surprise by President Clinton’s comments on world AIDS day and wish that someone had consulted with us before he made these comments.” …
  • …” We have always told the drug companies that we would not pressure them and create a slippery slope where prices they negotiate with us for poor countries would inevitably lead to similar prices in rich countries.” …
  • … “We would have to initiate discussions with multiple state health officials as well as HHS in addition to talking with the drug companies.” …
  • … “Whatever we decide, we need to make a decision quickly and President Clinton and CHAI need to be in synch. I do not think it is a good idea for President Clinton to be taking one position and CHAI another.” …

Is the Clinton Foundation Responsible for the High Price of AIDS Drugs in the US? - HUFFINGTON POST
DEC 30, 2016

  • “If you really had to think long and hard about it, the ultimate result of years of negotiations by the Clinton Foundation was that the price of AIDS drugs ended up being high in the US.”
  • “Furthermore, African governments were paranoid that drug companies were a part of a massive conspiracy suppressing their countries.”

DonaldWashington

2

He continued that, despite this, the British government (who publicly backed the attack) refused requests "to resupply chloroquine in emergency relief until such time as the Sudanese can rebuild their pharmaceutical production". The factory was a principal source of Sudan's anti-malaria and veterinary drugs according to the CBW Conventions Bulletin. THE CBW CONVENTIONS BULLETIN

Coincidentally Malaria Spirals Out of Control

Malaria Surveillance - United States, 1999 - CENTERS FOR DISEASE CONTROL
”Interpretation:”

  • “The 25.5% increase in malaria cases in 1999, compared with 1998, resulted primarily from increases in cases acquired in Africa and the Americas.”

    • “This increase is possibly related to a change in the system by which states report to CDC, but it could also have resulted from local changes in disease transmission, increased travel to these regions, improved reporting to state and local health departments, or a decreased use of effective antimalarial chemoprophylaxis.
  • “In the majority of reported cases, U.S. civilians who acquired infection abroad were not on an appropriate chemoprophylaxis regimen for the country where they acquired malaria.”


Public Complain of Malaria Vaccine Shortage - GHANA WEB
NOV 3, 2000

  • The general public has raised concern and doubt over malaria vaccines, which they said are running short in health centres.

  • In an interview in health centres, members of the public expressed 'strong interest', calling for 'immediate' explanation from the health department over what they saw as the acute shortage of chloroquine vaccines at a time when malaria is taking a high toll on the population.

Time to act! What can USAID do for you?

United States Agency for International Development USAID's programs are authorized by the Congress in the Foreign Assistance Act, which the Congress supplements through directions in annual funding appropriation acts and other legislation. Although it is technically an independent agency, USAID operates subject to the foreign policy guidance of the President, Secretary of State, and the National Security Council. USAID operates in Africa, Asia, Latin America, the Middle East, and Eastern Europe.

Evaluating Malaria Interventions In Africa: A Review and Assessment of Recent Research - USAID
NOV 1999

  • “According to the most recent data, 40% (2,400 million) of the world population in over 90 countries is affected by malaria. In any given year, nearly 10% of the global population will suffer a case of malaria (Malaria International, 1998).”

  • “There are 300 - 500 million clinical cases of malaria worldwide each year with the majority occurring in sub-Saharan Africa (WHO, 1998).”

  • “Malaria has been estimated to cause 9% of all disease in Africa (Nchinda, 1998).”

  • “According to recent data, there are 1.5 – 2.7 million deaths due to malaria each year, the bulk of which occur in sub-Saharan Africa where an estimated 360 million people live in areas of stable, endemic Plasmodium falciparum transmission (Snow et al., 1999a).”


Rolling Back Malaria - WORLD HEALTH ORGANIZATION - 1999

  • Almost 300 million clinical cases of malaria occur worldwide each year and over one million people die.

  • Almost 90% of these deaths occur in sub-Saharan Africa, where young children are the most affected.

  • Malaria is directly responsible for one in five childhood deaths in Africa and indirectly contributes to illness and deaths from respiratory infections, diarrheal disease and malnutrition.

The author then uses good information in a manner that is very misleading.

  • “Chloroquine, perhaps the best ever antimalarial drug, and certainly the most widely used, is now failing against falciparum malaria in most areas of the tropical world.”

True

  • “In some areas, such as parts of South-East Asia and South America, chloroquine is now completely ineffective against P. falciparum malaria.”

True, but we’re talking about Africa. That’s where the problem is.

  • “In many parts of India and Africa, its effectiveness is falling rapidly.”

True, but still misleading. Per the National Center for Biotechnology (NCBI), “despite declining use, CQ remained the first-line therapy for uncomplicated P.f. malaria in the majority of sub-Saharan countries until after 2000.” - US NATIONAL LIBRARY OF MEDICINE

  • “For the treatment of falciparum malaria, the usual successor to chloroquine is a combination of pyrimethamine and a long acting sulphonamide (SP), which is also affordable and well tolerated. Five countries in Africa (Botswana, Kenya, Malawi, South Africa and Swaziland) have now been forced to switch from chloroquine to SP as the first line antimalarial treatment.”

  • “Unfortunately, in several of the areas where it has been deployed, notably South-East Asia and South America, P. falciparum has become widely SP-resistant.”

I thought we were talking about sub-Saharan Africa.

The truth is, the resurgence of malaria is in large part, the result of Bill Clinton’s destabilization of Africa. (Ok Bush too, but we will discuss that later)

WHO backs controversial chemical for malaria control - SCI DEV NET
SEP 18, 2006

  • The controversial insecticide DDT — which most nations have banned — is back on the menu for malaria control after the World Health Organization reversed a 30-year old policy on Friday (15 September).

  • The move puts annual indoor spraying of DDT alongside drugs and bednets as one of the three main tools for controlling the disease.

  • "The scientific and programmatic evidence clearly supports this reassessment," said Anarfi Asamoa-Baah, assistant director-general for HIV/AIDS, TB and malaria at the World Health Organization (WHO).

  • "[Indoor spraying] has proven to be just as cost-effective as other malaria prevention methods, and DDT presents no health risk when used properly."

  • The chemical kills the mosquitoes that spread malaria. It helped eradicate the disease from southern Europe and North America in the 1960s.

  • DDT is also toxic to birds, fish and mammals. It accumulates in the food chain and remains in the environment for many years. In the 1970s, growing awareness of these threats led many countries to ban its use in agriculture.


Malaria linked to catastrophic spread of AIDS in Africa - SCI DEV NET
DEC 8, 2006

  • Research in Kenya indicates that the rapid spread of HIV/AIDS across Africa could be linked to malaria.

  • The work has important implications for public health policies in sub-Saharan Africa, highlighting the need to tackle both diseases together.

  • There is considerable geographical overlap between HIV/AIDS — which infects over 40 million people in Africa — and malaria, which causes 500 million clinical infections each year.

  • People with both malaria and HIV/AIDS are more likely to transmit the HIV virus, according to the study published in the journal Science today (8 December). This may have promoted the rapid spread of the disease in sub-Saharan Africa.

  • "We have always known the relationship between [malaria and HIV/AIDS], but we did not know the impact it had on the spread: now we have a reference point," says Ayub Manya, an epidemiologist with the Kenyan National Malaria Control Programme.